Literature DB >> 1684265

Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease.

T Ohgami1, T Kitamoto, A Weidmann, K Beyreuther, J Tateishi.   

Abstract

To clarify the relationship between amyloid formation and amyloid precursor protein (APP), the brain sections from eight patients with Alzheimer's disease (AD) and four with Gerstmann-Sträussler Syndrome (GSS) were investigated immunohistochemically by the double-immunostaining method. In AD, most APP-positive senile plaques belong to classical plaques or primitive plaques, whereas in diffuse plaques, APP-positive neuritic components are rarely observed. The authors documented that anti-APP-labeled degenerative neurites surrounding kuru plaques in all four GSS patients. These kuru plaques were verified by double immunostaining using anti-prion protein and anti-APP. The APP-positive structures in kuru plaques were almost identical with those seen in the classical plaques in AD. The authors concluded that APP-positive degenerative neurites are not an early event in the amyloid formation of senile plaques. It is therefore postulated that depositions of beta/A4 and prion proteins are primary events that may involve the surrounding microenvironment and result in the secondary formation of APP-positive degenerative neurites, not specific to AD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684265      PMCID: PMC1886475     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Central nervous system amyloidoses: a comparison of Alzheimer's disease and Creutzfeldt-Jakob disease.

Authors:  P Brown
Journal:  Neurology       Date:  1989-08       Impact factor: 9.910

2.  Ubiquitin conjugate immunoreactivity in the brains of scrapie infected mice.

Authors:  J Lowe; H McDermott; N Kenward; M Landon; R J Mayer; M Bruce; P McBride; R A Somerville; J Hope
Journal:  J Pathol       Date:  1990-09       Impact factor: 7.996

3.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

4.  Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains.

Authors:  S Ikeda; N Yanagisawa; D Allsop; G G Glenner
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

5.  Increased senile plaques without microglia in Alzheimer's disease.

Authors:  T Ohgami; T Kitamoto; R W Shin; Y Kaneko; K Ogomori; J Tateishi
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease.

Authors:  K Ogomori; T Kitamoto; J Tateishi; Y Sato; M Suetsugu; M Abe
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

7.  Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.

Authors:  C Joachim; D Games; J Morris; P Ward; D Frenkel; D Selkoe
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

8.  Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues.

Authors:  R W Shin; T Iwaki; T Kitamoto; J Tateishi
Journal:  Lab Invest       Date:  1991-05       Impact factor: 5.662

9.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease.

Authors:  R E Tanzi; A I McClatchey; E D Lamperti; L Villa-Komaroff; J F Gusella; R L Neve
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

10.  A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors.

Authors:  P Ponte; P Gonzalez-DeWhitt; J Schilling; J Miller; D Hsu; B Greenberg; K Davis; W Wallace; I Lieberburg; F Fuller
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

View more
  6 in total

1.  Differential expression of CD44 variants among meningioma subtypes.

Authors:  S O Suzuki; T Iwaki; T Kitamoto; M Mizoguchi; M Fukui; J Tateishi
Journal:  Clin Mol Pathol       Date:  1996-06

2.  Hereditary cerebral hemorrhage with amyloidosis (Dutch): a model for congophilic plaque formation without neurofibrillary pathology.

Authors:  M L Maat-Schieman; C M Radder; S G van Duinen; J Haan; R A Roos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

3.  Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes.

Authors:  H Yamaguchi; T Yamazaki; K Ishiguro; M Shoji; Y Nakazato; S Hirai
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

4.  Wet autoclave pretreatment for immunohistochemical demonstration of oestrogen receptors in routinely processed breast carcinoma tissue.

Authors:  B Bier; A Bankfalvi; L Grote; S Blasius; D Ofner; W Böcker; B Jasani; K W Schmid
Journal:  Histochem J       Date:  1995-02

Review 5.  Transmissible cerebral amyloidoses as a model for Alzheimer's disease. An ultrastructural perspective.

Authors:  P P Liberski
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

6.  An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid.

Authors:  Keisuke Ishizawa; Takashi Mitsufuji; Kei Shioda; Atsushi Kobayashi; Takashi Komori; Yoshihiko Nakazato; Tetsuyuki Kitamoto; Nobuo Araki; Toshimasa Yamamoto; Atsushi Sasaki
Journal:  Brain Behav       Date:  2018-09-21       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.